Medicare Advantage's Quality Bonus Program: A Deep Dive into Spending and Enrollments
The Medicare Advantage Quality Bonus Program, a cornerstone of the Affordable Care Act, has been a subject of intense scrutiny and debate. This program, designed to incentivize plans with high-quality ratings, has seen its spending surge to over $13 billion in 2026, a more than fourfold increase since 2015. But what does this mean for the program, and how does it impact the broader healthcare landscape?
The Rising Cost of Quality
In my opinion, the most striking aspect of this program is its escalating cost. From $3.0 billion in 2015 to over $13 billion in 2026, the spending on the quality bonus program has grown exponentially. This is particularly concerning given the program's original intent to encourage quality improvements. What makes this even more intriguing is the fact that the spending growth has outpaced the increase in Medicare Advantage enrollment, which has only doubled since 2015.
Enrollments and Plan Types
What's more, the program's impact varies across plan types. Employer- and union-sponsored plans, which account for 20% of spending, see the highest average increase in payments per person ($466), while special needs plans, which serve higher-need beneficiaries, see the lowest increase ($318). This disparity raises questions about the program's effectiveness in addressing the needs of all enrollees.
Insurers and Their Share
The distribution of spending across insurers is also noteworthy. UnitedHealth Group, with over a quarter of enrollees, is expected to receive 29% of total Medicare spending under the quality bonus program, or $3.9 billion in 2026. This is in stark contrast to Humana Inc., which has the second-largest share of enrollment but receives only 11% of the bonus spending, or $1.5 billion.
Star Ratings and Their Impact
The star rating system, a key feature of the program, is under scrutiny. Plans with at least four stars are eligible for increased payments, but the criteria for achieving these ratings are constantly changing. In 2026, only 68% of enrollees were in plans that qualified for the quality bonus program, down from 75% in 2025. This decline is partly due to changes in the cut points for star ratings.
The Broader Implications
The quality bonus program's impact extends beyond the program itself. It exacerbates the effects of higher coding intensity and favorable selection in Medicare Advantage, adding $76 billion to Medicare spending in 2026. This raises a deeper question: Are these increases in spending truly reflective of improved quality, or are they driven by other factors?
Looking Ahead
As we look to the future, the program's sustainability and effectiveness will be crucial. The CMS's recent changes to the star ratings system, while a step towards simplification, are projected to increase spending by $18.6 billion over the next 10 years. This raises the question: How will these changes impact the program's overall cost and effectiveness?
In conclusion, the Medicare Advantage Quality Bonus Program is a complex and evolving aspect of healthcare policy. Its rising cost, varying impact across plan types, and the role of star ratings all contribute to a multifaceted discussion. As we continue to analyze and interpret these trends, one thing is clear: the program's future will have significant implications for both the healthcare system and the broader economy.
